Role of Xpert MTB/RIF in Bronchoalveolar lavage fluid of sputum-scarce, suspected Pulmonary TB patients.

Autor:	Kilaru SC; Department of Respiratory Medicine, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India., Chenimilla NP; Department of Respiratory Medicine, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India., Syed U; Department of Respiratory Medicine, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India., Momin K; Department of Community Medicine, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India., Kilaru H; Department of Respiratory Medicine, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India., Patil E; Department of Microbiology and Serology, SRL Diagnostics, Mumbai, India., Nerurkar V; Department of Microbiology and Serology, SRL Diagnostics, Mumbai, India.
Jazyk:	angličtina
Zdroj:	Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2018 Dec 01; Vol. 14, pp. 7-11. Date of Electronic Publication: 2018 Dec 01 (Print Publication: 2019).
DOI:	10.1016/j.jctube.2018.11.003
Abstrakt:	Setting: A prospective observational study conducted in Medical college hospital, in a high-TB- prevalence region of northern Telangana, India. Objective: To know the diagnostic role of Xpert MTB/RIF assay in bronchoalveolar lavage fluid (BALF) in sputum-scarce, suspected pulmonary tuberculosis (PTB) patients. Design: Study period was between October 2014 and March 2017. Suspected pulmonary tuberculosis patients aged 15 years or more, who were sputum-scarce and conforming to the inclusion criteria were submitted to bronchoscopy. BALF thus obtained was submitted to smear for acid fast bacilli (AFB) and Xpert MTB/RIF assay as index tests along with culture for Mycobacterium tuberculosis complex (MTBC). Culture for M. tuberculosis complex was considered as gold standard for the diagnosis of PTB. The sensitivity, specificity and predictive values were calculated for smear AFB and Xpert MTB/RIF assay. Results: 56 of the 81 patients were included and evaluated in the final analysis. In 10 of these 56 patients PTB was confirmed by culture positivity. The sensitivity and specificity of Xpert MTB/RIF assay was 90% (9/10,95%CI 59.6- 98.2) and 52.2% (24/46, 95%CI 38. 1-65.9) respectively and that of the smear AFB was 60% (6/10, 95%CI 31.2-83.1) and 67.4% (31/46, 95%CI 53.0-79.1). All the patients considered 'probable' PTB (pending culture results), were administered antituberculous treatment and showed complete clinicoradiological improvement on follow up. Three of the 31 Xpert MTB/RIF positive patients were detected as resistance to rifampicin (RR). Conclusions: Xpert MTB/RIF assay of BALF in the study cohort provides rapid diagnosis of Mycobacterium tuberculosis , and detection of rifampicin resistance at the very outset, aiding in selection of appropriate ATT regimen. In this context, it can be recommended as the first line investigation. Xpert MTB/RIF assay aided by HRCT Chest and suggestive clinical presentation may be helpful in early institution of ATT especially in smear negative, culture negative cases. (© 2018 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu